The Globe and Mail (April 2016) published market research by Mackie Research Capital Corp. for the medical marijuana market in Canada. They estimate the market size to be at least $2.5 billion in 2020, contingent to the legalization of medical and recreational use. Forbes published reports from Arc View Market Research and New Frontier that estimated the market for legalized medical marijuana in the United States to grow at 26% from $4.6 billion in 2014 to $7.1 billion in 2016, despite the legal uncertainty it faces today.

Our research is structured such that the processes, intermediates and formulations will generate revenue at different time points.

The global market for Cannabis oils is estimated at >$1.5 billion and Akseera products will capture a part of the Canadian market, exporting from Health Canada approved, low cost manufacturing facilities in India.

Cannabis derived pharmaceuticals developed at Akseera are anticipated to treat at least some of the following indications*: